Studying kidney fat and donor kidney health
Part of Heart & circulation clinical trials.
This study asks whether the amount of fat around your kidney before donation can predict how your remaining kidney will do afterward. It follows living donors to see if that fat measurement relates to long-term kidney health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a living kidney donor.
- You meet the standard medical criteria for kidney donation at Mayo Clinic in Rochester.
- Your weight has not changed by more than 10% between evaluation and surgery.
- You are not pregnant and not planning to become pregnant.
- You are able to follow the study's procedures and appointments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are planning kidney donation or a kidney transplant to better understand how kidney function changes over time. It may help researchers predict risk and improve care by studying health markers in detail.
This trial looks at whether specific diet changes can be safely used for people who are planning a living kidney transplant. It mainly aims to understand how diet might affect people during the donation/transplant process.
This study looks at stored medical data from living liver donors to better understand fat in the liver (steatosis). It may help improve future transplant care.
This study looks at how well kidney transplants work from both living and deceased donors. It may help doctors better understand long-term outcomes for people who get a new kidney.
This study uses advanced MRI scans to look at kidney health in living donors, transplant recipients, and healthy people. It aims to find links between MRI results and kidney function, fibrosis (scarring), and aging.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.